BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38401631)

  • 1. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
    Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
    J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro and In-vivo Pharmacokinetic Evaluation of Guar Gum-Eudragit® S100 Based Colon-targeted Spheroids of Sulfasalazine Co-administered with Probiotics.
    Sharma A; Kumar B; Singh SK; Gulati M; Vaidya Y; ; Rathee H; Ghai D; Malik AH; Yadav AK; Maharshi P; Bawa P; Rajesh SY; Sharma P; Pandey NK; Mohanta S
    Curr Drug Deliv; 2018; 15(3):367-387. PubMed ID: 29219056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
    Patel MM; Amin AF
    Drug Deliv; 2011 May; 18(4):281-93. PubMed ID: 21138335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
    Vemula SK
    AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits.
    Nour SA; Abdelmalak NS; Naguib MJ
    Drug Deliv; 2015 May; 22(3):286-97. PubMed ID: 24601826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
    Mutalik S; Manoj K; Reddy MS; Kushtagi P; Usha AN; Anju P; Ranjith AK; Udupa N
    AAPS PharmSciTech; 2008; 9(2):651-9. PubMed ID: 18500561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
    Kshirsagar SJ; Bhalekar MR; Umap RR
    Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPTICORE™, an innovative and accurate colonic targeting technology.
    Varum F; Freire AC; Bravo R; Basit AW
    Int J Pharm; 2020 Jun; 583():119372. PubMed ID: 32344022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
    Shah N; Sharma OP; Mehta T; Amin A
    Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets.
    Vemula SK; Veerareddy PR
    Expert Opin Drug Deliv; 2013 Jan; 10(1):33-45. PubMed ID: 23199134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
    Leopold CS; Eikeler D
    J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
    Tiwari R; Gupta A; Joshi M; Tiwari G
    PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of budesonide compression-coated tablets for colonic delivery.
    Yehia SA; Elshafeey AH; Sayed I; Shehata AH
    AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
    Vemula SK
    Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography.
    Sharma P; Pathak K
    AAPS PharmSciTech; 2013 Jun; 14(2):736-47. PubMed ID: 23615771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
    Xu M; Sun M; Qiao H; Ping Q; Elamin ES
    Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.